| Value | ₹552.5 Cr |
|---|---|
| Execution period | 10 working days |
BSE filing, NSE: NOVARTIND. Summary written from the filing by ALFA Finder's alert engine.
Novartis India Ltd: key numbers
- Share price
- ₹1,805.95
- Market cap
- ₹4,459 Cr
- Revenue (annual)
- ₹354.3 Cr
- Net profit (annual)
- ₹93.18 Cr
- P/E (TTM)
- 45.6×Sector 46.1×
- Promoter holding
- 70.68%+0.00% QoQ
- FII holding
- 1.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Novartis India Ltd
All →Novartis India Management Change
Evonile Pharma (formerly Novartis India) appointed Mr. Gagan Sharma as President – Specialty Business and Senior Management Personnel effective October 26, 2026. The filing is a Regulation 30 senior management appointment intimation.
Novartis India Other Announcement
Novartis India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations. This is a routine periodic disclosure.
Novartis India Annual General Meeting
Evonile Pharma (fka Novartis India) issued a postal ballot notice for shareholder votes on ESOP 2026 grant to the MD & CEO and creation of charge on assets. E-voting runs 14 Oct–12 Nov 2026.
Novartis India Fund Raise of ₹900 Cr
Evonile Pharma Limited approved a rights issue to raise up to ₹900 Crore. The company also formed a committee to manage the issuance terms.
- Value
- ₹900.0 Cr
Novartis India Credit Rating
Evonile Pharma Limited has received credit ratings from CARE Ratings Limited for its bank facilities. The company disclosed the ratings as part of its regulatory filings.
Novartis India Other Announcement
Novartis India Limited has changed its corporate name to Evonile Pharma Limited, effective October 01, 2026, following approval from the Ministry of Corporate Affairs.
Other open offer announcements
All →Comrade Appliances Open Offer: ₹9.26 Cr
Manager Corporate Professionals filed the draft letter of offer for a mandatory open offer for Comrade Appliances by four acquirers. They seek up to 26.46 lakh shares, 26% of expanded capital, at Rs 35 per share.
- Value
- ₹9.26 Cr
Genomic Valley Biotech Open Offer: ₹57.97 Cr
Manager to the Open Offer filed GVB's DPS announcing an open offer for up to 7,94,170 shares at ₹730. The Acquirers seek about 21% of the company.
- Value
- ₹57.97 Cr
Inani Securities Open Offer: ₹7.11 Cr
Aikyam Financial Services is acquiring 11.85 lakh Inani Securities shares at ₹60 each via SAST open offer. The DLOO was submitted to BSE for processing.
- Value
- ₹7.11 Cr
Kuber Udyog Open Offer: ₹74.65 Cr
Manager to the Offer filed Pre-Offer PA for an open offer to acquire 26% of Kuber Udyog at ₹23.35 per share. Tendering period begins October 28, 2026.
- Value
- ₹74.65 Cr
Ishaan Infrastructures & Shelters Open Offer: ₹8.89 Cr
Novus Capital filed the Letter of Offer for an open offer of 63,48,500 Ishaan Infrastructures shares at Rs.14. Tendering opens November 2, 2026.
- Value
- ₹8.89 Cr
Pasupati Fincap Open Offer
Fintellectual, Manager to the Open Offer, filed the Post-Offer Advertisement under SAST Reg 18(12). It covers Uday Narang's offer for up to 12.22 lakh Pasupati Fincap shares.